Abstract
MEK proteins play a critical role in tumor proliferation, differentiation, and survival. Hence MEK1 inhibitors are of particular importance in the treatment of related diseases. The present study describes pharmacophore-based 3DQSAR model generation based on 82 known inhibitors of MEK1 allosteric binding cavity. The best pharmacophore model developed consisted of four features, namely AHHR. The model was used as a query to screen the databases of almost 1.3 million compounds. Finally, 8 hits were indentified and the docking study manifested that these compounds interacted with MEK1 well. Finally, 10 ns MD simulations of the obtained ligand-receptor system were performed. The stable binding mode of the system was determined. Our results showed that the identified 8 hits would be useful for the development of potent MEK1 agents.
Keywords: 3D-QSAR, Allosteric binding cavity, MD simulations, MEK1, Molecular docking, Virtual screening.
Letters in Drug Design & Discovery
Title:Identification of Potential MEK1 Inhibitors by Pharmacophore-based Virtual Screening and MD Simulations
Volume: 11 Issue: 7
Author(s): Huanhuan Shi, Lu Zhou, Guangkai Bao, Qianying Yi, Suwen Zhou, Yahui Tian and Xiaoli Li
Affiliation:
Keywords: 3D-QSAR, Allosteric binding cavity, MD simulations, MEK1, Molecular docking, Virtual screening.
Abstract: MEK proteins play a critical role in tumor proliferation, differentiation, and survival. Hence MEK1 inhibitors are of particular importance in the treatment of related diseases. The present study describes pharmacophore-based 3DQSAR model generation based on 82 known inhibitors of MEK1 allosteric binding cavity. The best pharmacophore model developed consisted of four features, namely AHHR. The model was used as a query to screen the databases of almost 1.3 million compounds. Finally, 8 hits were indentified and the docking study manifested that these compounds interacted with MEK1 well. Finally, 10 ns MD simulations of the obtained ligand-receptor system were performed. The stable binding mode of the system was determined. Our results showed that the identified 8 hits would be useful for the development of potent MEK1 agents.
Export Options
About this article
Cite this article as:
Shi Huanhuan, Zhou Lu, Bao Guangkai, Yi Qianying, Zhou Suwen, Tian Yahui and Li Xiaoli, Identification of Potential MEK1 Inhibitors by Pharmacophore-based Virtual Screening and MD Simulations, Letters in Drug Design & Discovery 2014; 11 (7) . https://dx.doi.org/10.2174/1570180811666140423221748
DOI https://dx.doi.org/10.2174/1570180811666140423221748 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Deciphering Transcriptional Regulation Relevant to Eating Behavior
Current Genomics Plasminogen Activation-Based Thrombolysis for Ischaemic Stroke: The Diversity of Targets may Demand New Approaches
Current Drug Targets The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine
Current Molecular Medicine Recent Patents on Interventional Robot for Prostate Cancer
Recent Patents on Mechanical Engineering Main Anti-tumor Angiogenesis Agents Isolated From Chinese Herbal Medicines
Mini-Reviews in Medicinal Chemistry NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress
Current Cancer Drug Targets Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target
Current Drug Discovery Technologies Anticipation in Lynch Syndrome: Where We Are Where We Go
Current Genomics Expression of Fucosyltransferases Contributes to Melanoma Invasive Phenotype
Medicinal Chemistry Flavonoids with Therapeutic Potential in Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Flavonoids as Multi-Target Compounds in Drug Discovery
Mini-Reviews in Organic Chemistry Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Current Vascular Pharmacology Gold Nanostructure: Fabrication, Surface Modification, Targeting Imaging, and Enhanced Radiotherapy
Current Nanoscience The Contractile Properties of Airway Smooth Muscle: How their Defects can be Linked to Asthmatic Airway Hyperresponsiveness?
Current Respiratory Medicine Reviews Insights in microRNAs Biology
Current Topics in Medicinal Chemistry How and Why to Screen for CYP2D6 Interindividual Variability in Patients Under Pharmacological Treatments
Current Drug Metabolism Endocannabinoid Regulation of Matrix Metalloproteinases: Implications in Ischemic Stroke
Cardiovascular & Hematological Agents in Medicinal Chemistry Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Toll-Like Receptors: Cost or Benefit for Cancer?
Current Pharmaceutical Design Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy
Current Neuropharmacology